Unknown

Dataset Information

Engineered protein and Jakinib nanoplatform with extraordinary rheumatoid arthritis treatment.


ABSTRACT: Rheumatoid arthritis (RA) is a relatively common inflammatory disease that affects the synovial tissue, eventually results in joints destruction and even long-term disability. Although Janus kinase inhibitors (Jakinibs) show a rapid efficacy and are becoming the most successful agents in RA therapy, high dosing at frequent interval and severe toxicities cannot be avoided. Here, we developed a new type of fully compatible nanocarriers based on recombinant chimeric proteins with outstanding controlled release of upadacitinib. In addition, the fluorescent protein component of the nanocarriers enabled noninvasive fluorescence imaging of RA lesions, thus allowing real-time detection of RA therapy. Using rat models, the nanotherapeutic is shown to be superior to free upadacitinib, as indicated b

SUBMITTER: Li Y 

PROVIDER: S-EPMC10256963 | biostudies-literature | 2023 Jun

REPOSITORIES: biostudies-literature